A Klajman

1.9k total citations
56 papers, 1.5k citations indexed

About

A Klajman is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, A Klajman has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in A Klajman's work include Immune Cell Function and Interaction (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and T-cell and B-cell Immunology (8 papers). A Klajman is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and T-cell and B-cell Immunology (8 papers). A Klajman collaborates with scholars based in Israel, United States and United Kingdom. A Klajman's co-authors include Joseph Holoshitz, A. Frenkel, Willem van Eden, Zvi Nevo, Irun R. Cohen, Zeev Steiner, H Rabinowich, Ilana Drucker, P. Efrati and I Bruderman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

A Klajman

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Klajman Israel 16 692 360 317 254 240 56 1.5k
P M Lydyard United Kingdom 20 1000 1.4× 300 0.8× 205 0.6× 231 0.9× 181 0.8× 49 1.6k
S. Kishimoto Japan 19 575 0.8× 349 1.0× 151 0.5× 119 0.5× 170 0.7× 61 1.5k
E R de Groot Netherlands 15 945 1.4× 291 0.8× 166 0.5× 280 1.1× 240 1.0× 17 1.7k
Takatoshi Inoue Japan 19 593 0.9× 340 0.9× 332 1.0× 224 0.9× 101 0.4× 63 1.4k
Gilbert J. Fournié France 25 1.0k 1.5× 608 1.7× 425 1.3× 379 1.5× 230 1.0× 75 2.3k
Junichi Yata Japan 25 1.0k 1.5× 368 1.0× 164 0.5× 124 0.5× 219 0.9× 105 1.9k
H Loetscher Switzerland 14 1.2k 1.7× 514 1.4× 223 0.7× 164 0.6× 307 1.3× 15 1.9k
J F Leeuwenberg Netherlands 21 1.1k 1.5× 439 1.2× 117 0.4× 328 1.3× 241 1.0× 31 2.0k
Chau‐Ching Liu United States 26 1.1k 1.6× 405 1.1× 433 1.4× 174 0.7× 206 0.9× 52 1.8k
Paula Jardieu United States 30 1.3k 1.9× 488 1.4× 352 1.1× 566 2.2× 168 0.7× 54 3.3k

Countries citing papers authored by A Klajman

Since Specialization
Citations

This map shows the geographic impact of A Klajman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Klajman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Klajman more than expected).

Fields of papers citing papers by A Klajman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Klajman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Klajman. The network helps show where A Klajman may publish in the future.

Co-authorship network of co-authors of A Klajman

This figure shows the co-authorship network connecting the top 25 collaborators of A Klajman. A scholar is included among the top collaborators of A Klajman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Klajman. A Klajman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drucker, Ilana, A Klajman, Michel Revel, et al.. (1997). Interleukin‐6 and interleukin‐6 receptor secretion by chronic lymphatic leukaemia and normal B lymphocytes: effect of PMA and PWM. Mediators of Inflammation. 6(2). 147–153. 3 indexed citations
2.
Drucker, Ilana, Shlomo Ben‐Efraim, & A Klajman. (1996). Secretion of suppressor factors by EBV infected B cell lines.. PubMed. 16(5A). 2857–61. 1 indexed citations
3.
Ben‐Efraim, Shlomo, et al.. (1991). Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures. Cancer Immunology Immunotherapy. 34(3). 181–185. 8 indexed citations
4.
Mekori, Yoseph A., Dana Baram, Arnon Goldberg, & A Klajman. (1989). Inhibition of delayed hypersensitivity reactions in mice by colchicine. Cellular Immunology. 120(2). 330–340. 19 indexed citations
5.
Mekori, Yoseph A., et al.. (1989). Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line.. PubMed. 78(2). 230–2. 20 indexed citations
6.
Radnay, Judith, et al.. (1988). Malignant thymoma with peripheral blood lymphocytosis. Cancer. 61(6). 1222–1227. 13 indexed citations
7.
Shoenfeld, Yehuda, et al.. (1987). Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide. Journal of Clinical Immunology. 7(5). 410–419. 14 indexed citations
8.
Rabinowich, H, Mark Lyte, Zeev Steiner, A Klajman, & Meir Shinitzky. (1987). Augmentation of mitogen responsiveness in the aged by a special lipid diet AL 721. Mechanisms of Ageing and Development. 40(2). 131–138. 6 indexed citations
9.
Manor, Yosef, et al.. (1987). Long-term cultures of chronic lymphocytic leukemia B cells generate B suppressor cells. Clinical Immunology and Immunopathology. 42(2). 171–182. 3 indexed citations
10.
Manor, Yael, et al.. (1986). Generation of B suppressor cells by phytohaemagglutinin.. PubMed Central. 57(3). 395–8. 7 indexed citations
11.
Eden, Willem van, Joseph Holoshitz, Zvi Nevo, et al.. (1985). Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.. Proceedings of the National Academy of Sciences. 82(15). 5117–5120. 369 indexed citations
12.
Klajman, A, Ilana Drucker, Yosef Manor, & Shlomo Ben‐Efraim. (1984). In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cells. Cancer Immunology Immunotherapy. 18(2). 113–7. 11 indexed citations
13.
Klajman, A, Ilana Drucker, & Yosef Manor. (1983). Autologous mixed lymphocyte reaction in man: Further characterization of responding cells. Immunology Letters. 6(1). 13–19. 1 indexed citations
14.
Klajman, A, et al.. (1983). The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid-like disease. Clinical Immunology and Immunopathology. 27(1). 1–8. 22 indexed citations
15.
Becker, Martin, et al.. (1981). Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing.. PubMed. 45(2). 439–46. 7 indexed citations
16.
Becker, Martin, et al.. (1979). Circulating immune complexes in sera from patients receiving procainamide. Clinical Immunology and Immunopathology. 12(2). 220–227. 12 indexed citations
17.
Manor, Yael, et al.. (1978). Successful postmortem cesarean section in a case of fulminant pneumococcal meningitis.. PubMed. 14(2). 287–8. 4 indexed citations
18.
Klajman, A, et al.. (1976). Renal Handling of the Third (C3) and Fourth (C4) Components of the Complement System in the Nephrotic Syndrome. ˜The œNephron journals/Nephron journals. 16(5). 333–343. 9 indexed citations
19.
Klajman, A, et al.. (1970). Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.. PubMed. 7(5). 641–9. 25 indexed citations
20.
Klajman, A, et al.. (1960). [An outbreak of an epidemic of benign myalgic encephalomyelitis].. PubMed. 58. 314–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026